{
  "id": "58dfd70c6fddd3e83e000002",
  "type": "factoid",
  "question": "What is the results of inactivated ANGPLT3?",
  "ideal_answer": "Complete ANGPTL3 deficiency caused by loss-of-function mutations of ANGPTL3 is associated with a recessive hypolipidemia",
  "documents": [
    "http://www.ncbi.nlm.nih.gov/pubmed/24798233",
    "http://www.ncbi.nlm.nih.gov/pubmed/22062970"
  ],
  "snippets": [
    {
      "text": "Although it appears by now that the main lipid pathways have been uncovered, and that only modulators or adaptor proteins such as those encoded by LDLRAP1, APOA5, ANGPLT3/4, and PCSK9 are currently being discovered",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/24798233",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Angptl3 knockout mice have marked hypolipidemia, and heterozygous carriers of ANGPLT3, loss-of-function mutations were found among individuals in the lowest quartile of plasma triglycerides in population studies. ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/22062970",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": " 4 related individuals with primary hypolipidemia were found to be compound heterozygotes for ANGPTL3 loss-of-function mutations.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/22062970",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Complete ANGPTL3 deficiency caused by loss-of-function mutations of ANGPTL3 is associated with a recessive hypolipidemia",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/22062970",
      "beginSection": "abstract",
      "endSection": "abstract"
    }
  ],
  "concepts": [],
  "exact_answer": "Recessive hypolipidemia"
}